DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 208 filers reported holding DENALI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $236 | +4.0% | 11 | 0.0% | 0.00% | – |
Q3 2023 | $227 | -30.2% | 11 | 0.0% | 0.00% | – |
Q2 2023 | $325 | +28.5% | 11 | 0.0% | 0.00% | – |
Q1 2023 | $253 | -17.3% | 11 | 0.0% | 0.00% | – |
Q4 2022 | $306 | – | 11 | +83.3% | 0.00% | – |
Q3 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 6 | 0.0% | 0.00% | – |
Q3 2021 | $0 | -100.0% | 6 | -40.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 10 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 10 | -37.5% | 0.00% | – |
Q4 2020 | $1,000 | – | 16 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $404,042,000 | 54.41% |
Bratton Capital Management, L.P. | 953,035 | $19,785,000 | 29.05% |
Flagship Pioneering Inc. | 8,005,747 | $166,199,000 | 7.19% |
Casdin Capital, LLC | 400,000 | $8,304,000,000 | 0.78% |
Temasek Holdings (Private) Ltd | 4,410,457 | $91,561,000 | 0.65% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 22,595 | $469,000 | 0.37% |
MARK ASSET MANAGEMENT LP | 70,532 | $1,464,000 | 0.34% |
Artal Group S.A. | 400,000 | $8,304,000 | 0.34% |
PIER 88 INVESTMENT PARTNERS LLC | 27,650 | $574,000 | 0.24% |
WASATCH ADVISORS LP | 996,147 | $20,680,000 | 0.20% |